Polygenic testing is best considered as a screening tool rather than a diagnostic tool, as a function of the underlying methodology. As a screening tool, PGS can be used as either a standalone risk estimate, or as one component alongside additional factors like monogenic risk, family history, and clinical/environmental/behavioral health history in an integrated risk model.